medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2021, Number 4

<< Back

An Med Asoc Med Hosp ABC 2021; 66 (4)

ABC Cancer Center, more than a decade of Cancer Care in Mexico

Gerson CR

Language: Spanish
References: 18
Page: 297-311
PDF size: 380.44 Kb.


ABSTRACT

The ABC Hospital's Cancer Center began operations in 2009 with the following subspecialties: medical oncology, radiotherapy, and oncosurgery, all tied to units dedicated to supporting patients and their loved ones. Afterwards, further investment and increased focus on academics led to the establishment of clinicopathological programs and collegiate sessions. Radiosurgery was added in 2012, and linear accelerators in 2020. Parallel to the addition of ambulatory chemotherapy cubicles came modules for immunotherapy and biotherapy. A rigorous union between attentive patient care, dedication to investigation, and tracking the rising incidence of cancer and increasing life expectancy characterizes every Center innovation. The Center itself is a standard for academic achievement and teaching, including the approval of university level courses for the subspecialty in medical oncology. The Center counts with many services: distribution of pharmaceuticals, infusions, transfusions, parenteral feeding, physiotherapy; nutrition, emotional and mental health, oncoimaging; all these joined together under the banner of wellness and life quality. Two main pillars inform the Center's approach: investigation and active teaching in mediated reunions for case studies. The development of investigative projects has birthed many programs integral to the Center's scientific prowess, including investigative molecular biology, DNA sequencing, cellular sampling and culturing, and stem cell research. Protocols advance daily with each new discovery. Our Medical Unit has even made a name for itself in the field of liquid biopsy with a progressive focus on individualized treatment and refined diagnostics; genomic breakthroughs led to the establishment of the High Specialty units and Hereditary Cancer Clinic. The Center's proactive and dynamic work focuses on precision-based treatment to thus detect risk factors, establish early diagnosis, and handle patients with the care they deserve. The goal is to become a benchmark for medical oncology and be recognised through international accreditation.


REFERENCES

  1. Institute of Medicine (US) Committee on Cancer Control in Low- and Middle-Income Countries. Cancer Control Opportunities in Low- and Middle-Income Countries. Sloan FA, Gelband H, editors. Washington (DC): National Academies Press (US); 2007. doi: 10.17226/11797.

  2. NCI-Designation and Accreditation; [Consulted 07 August 2021]; Available in: https://cancer.ucsf.edu/about/designation-and-accreditation

  3. Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: disease control priorities. Third edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 201. doi: 10.1596/978-1-4648-0349-9.

  4. Palacios GSA, Oropeza CR. Uso de herramientas tecnológicas por la seguridad del paciente: experiencia en México de la implementación del sistema Farmis-Oncofarm; Congreso Centroamericano y del Caribe de Ciencias Farmacéuticas, Panamá; 2013.

  5. Informática Médica Farmacéutica. [En línea]; [Citado 16 de marzo de 2020] Available in: http://www.imf.es

  6. Climente MM, Jiménez TNV. Manual para la atención farmacéutica. 3a ed. Edita: AFAHPE. Hospital Universitario Dr. Peset. Valencia, 2005.

  7. Tratamientos contra el cáncer, más allá de la quimioterapia. [En línea]; RDM, València, 24•10•19; Available in: https://www.levante-emv.com/branded-content/2019/10/24/tratamientos-cancer-quimioterapia-54990350.html

  8. Yang I, Udawatta M, Prashant GN, Lagman C, Bloch O, Jensen R et al. Stereotactic radiosurgery for neurosurgical patients: a historical review and current perspectives. World Neurosurg [Internet]. 2019; 122: 522-531. Available from: https://doi.org/10.1016/j.wneu.2018.10.193

  9. Ganz JC. Stereotactic and radiosurgery concepts in Sweden. Prog Brain Res. 2014; 215: 47-56.

  10. Beltrán JQ, Carrillo-Ruiz JD. Neurological functional surgery in Mexico: from pre-columbian cranial surgery to functional neurosurgery in the 21st century. World Neurosurg. 2019; 122: 549-558. Available in: https://doi.org/10.1016/j.wneu.2018.11.165

  11. The University of Kansas Cancer Center has been recognized as a National Cancer Institute (NCI)-designated cancer center since 2012; [Cited: 16 March 2020], Available in: https://www.kucancercenter.org/research/transformative-research/nci-designation

  12. UR Awarded $29 million for national leadership in cancer control research [In line]; [Cited September 30, 2019]; Available in: https://www.urmc.rochester.edu/news/story/ur-awarded-29-million-for-national-leadership-in-cancer-control-research

  13. Agur Z, Elishmereni M, Kheifetz Y. Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integration. Wiley Interdiscip Rev Syst Biol Med. 2014; 6 (3): 239-253.

  14. Helmy KY, Patel SA, Nahas GR, Rameshwar P. Cancer immunotherapy: accomplishments to date and future promise. Ther Deliv. 2013; 4 (10): 1307-1320. doi: 10.4155/tde.13.88.

  15. Vineis P, Wild CP. Global cancer patterns: causes and prevention. Lancet. 2014; 383 (9916): 549-557.

  16. Gopal S, Sharpless NE. Cancer as a global health priority. JAMA. 2021. doi: 10.1001/jama.2021.12778.

  17. Gerson S. Director's message [Access August 07, 2021]. Available in: https://case.edu/cancer/about-us/directors-message

  18. CMABC, Base de datos; Farmis-Oncofarm®.




2020     |     www.medigraphic.com